|

Dalpiciclib 100mg Clinical Trials

1 actively recruiting trial

▼ -1 trial since July 2026

Pipeline

Phase 2: 1

Top Sponsors

  • Fujian Cancer Hospital1

Indications

  • Endocrine Breast Diseases1
  • Dalpiciclib1
  • CDK4/6 Inhibitor1
  • HR+/HER2- Breast Cancer1
  • Breast Diseases1

Other1 trial

Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.